Yingying Hao Selected Research

Yingying Hao Research Topics

Disease

12	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2011
9	Neoplasms (Cancer) 01/2022 - 09/2010
8	Infections 01/2024 - 08/2013
6	Carcinoma (Carcinomatosis) 01/2020 - 12/2009
5	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2012
3	Carcinogenesis 01/2020 - 09/2010
3	Ovarian Epithelial Carcinoma 12/2017 - 01/2011
3	Lymphatic Metastasis 02/2015 - 06/2012
2	Glioma (Gliomas) 01/2022 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2020 - 09/2020
2	Pulmonary Hypertension 10/2020 - 09/2020
2	Endometrial Neoplasms (Endometrial Cancer) 02/2020 - 09/2015
1	Pulmonary Embolism 01/2024
1	Hypoalbuminemia 01/2024
1	Urinary Tract Infections (Urinary Tract Infection) 11/2023
1	Virus Diseases (Viral Diseases) 12/2022
1	Birth Weight (Birth Weights) 01/2022
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2022
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2021
1	Thrombocytopenia (Thrombopenia) 05/2021
1	Thrombosis (Thrombus) 05/2021
1	Critical Illness (Critically Ill) 05/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Cross Infection (Nosocomial Infection) 01/2021
1	Cognitive Dysfunction 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Headache (Headaches) 09/2020
1	Dyspnea (Shortness of Breath) 09/2020
1	Fibrosis (Cirrhosis) 04/2020
1	Pneumonia (Pneumonitis) 05/2019
1	Wounds and Injuries (Trauma) 04/2019
1	Severe Fever with Thrombocytopenia Syndrome 04/2019
1	Disease Progression 04/2019
1	Sepsis (Septicemia) 11/2018
1	Lung Diseases (Lung Disease) 09/2017

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 02/2020 - 01/2012
6	Lewis Y antigenIBA 12/2017 - 12/2009
5	Carbapenems (Carbapenem Antibiotics)IBA 01/2024 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2019
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2012
2	Serum AlbuminIBA 01/2024 - 01/2024
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 12/2022 - 09/2017
2	Therapeutic UsesIBA 11/2021 - 10/2013
2	Tigecycline (Tygacil)FDA Link 01/2021 - 05/2019
2	InterferonsIBA 01/2021 - 10/2013
2	Sildenafil Citrate (Viagra)FDA Link 10/2020 - 09/2020
2	CytokinesIBA 01/2020 - 01/2014
2	Immunoglobulin M (IgM)IBA 04/2019 - 01/2014
2	AntigensIBA 12/2017 - 01/2015
2	ParaffinIBA 09/2016 - 09/2015
1	Indicators and Reagents (Reagents)IBA 01/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2024
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022
1	Menotropins (Humegon)FDA LinkGeneric 11/2021
1	Letrozole (Femara)FDA LinkGeneric 11/2021
1	Clomiphene (Clomifene)FDA LinkGeneric 11/2021
1	Heparin (Liquaemin)FDA LinkGeneric 05/2021
1	AnticoagulantsIBA 05/2021
1	Lamivudine (Epivir)FDA Link 01/2021
1	Reverse Transcriptase InhibitorsIBA 01/2021
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 09/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2020
1	EnzymesIBA 04/2020
1	Alanine Transaminase (SGPT)IBA 04/2020
1	IridiumIBA 01/2020
1	2-phenylpyridineIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	PlakophilinsIBA 01/2020
1	Nucleocapsid ProteinsIBA 04/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2019
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	C-Reactive ProteinIBA 11/2018
1	ProcalcitoninIBA 11/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2018
1	HLA-DR Antigens (HLA-DR)IBA 11/2018
1	alpha-allylaminopropion-o-toluidide (L 134)IBA 11/2018
1	beta-lactamase NDM-1IBA 01/2018
1	FucoseIBA 12/2017
1	NF-kappa B (NF-kB)IBA 12/2017
1	Annexin A4IBA 12/2017
1	ChromatinIBA 12/2017
1	LuciferasesIBA 12/2017

Therapy/Procedure

8	Therapeutics 12/2022 - 10/2013
2	Immunotherapy 01/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 12/2017 - 02/2015
1	Extracorporeal Membrane Oxygenation 05/2021
1	Emergency Treatment 05/2021
1	Punctures 05/2021
1	Length of Stay 11/2018